Clinical Trials Market Share

Statistics for the 2023 & 2024 Clinical Trials market share, created by Mordor Intelligence™ Industry Reports. Clinical Trials share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Clinical Trials Industry

The clinical trials market is moderately competitive. Strategic partnerships between pharmaceutical companies and CROs are expected to impact the market's growth significantly. Also, the quick adoption of advanced technology for improved healthcare contributes to the growth of the market. Some of the key players are Clinipace, Eli Lilly and Company, Laboratory Corporation of America, ICON PLC, and Novo Nordisk AS.

Clinical Trial Market Leaders

  1. Clinipace

  2. Laboratory Corporation of America

  3. ICON PLC

  4. Eli Lilly and Company

  5. Novo Nordisk AS

*Disclaimer: Major Players sorted in no particular order

CL-Clinical trails market.png

Clinical Trials Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2024 - 2029)